Galena Biopharma to Present at the 15th Annual Bio CEO & Investor Conference
Galena Biopharma to Present at the 15th Annual Bio CEO & Investor Conference LAKE OSWEGO, Ore., Feb. 5, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer, will present a corporate update at the 15^th Annual BIO CEO & Investor Conference. The presentation will take place on Monday, February 11th, 2013 at 9:00 AM EST at the Waldorf Astoria Hotel, New York, NY. The presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com. About Galena Biopharma Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based biopharmaceutical company that develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit us at www.galenabiopharma.com. The Galena Biopharma, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10647 CONTACT: Madeline Hatton Toll free: +1 (855) 855-GALE (4253), ext. 109 firstname.lastname@example.org or Remy Bernarda IR Sense, LLC +1 (503) 400-6995 email@example.com Galena Biopharma, Inc.